原发性眼眶黑色素瘤的基因图谱:6例临床病理相关性分析
该回顾性非干预研究分析了6例原发性眼眶黑色素瘤的基因图谱与临床病理特征。6例中3例死于黑色素瘤转移,染色体获得最常见于6p、8q、17q、6q和20p,突变见于GNAQ、GNA11、SF3B1、NRAS和pTERT。数据提示原发性眼眶黑色素瘤存在两类基因群:类结膜黑色素瘤群和类葡萄膜黑色素瘤群。
要点
- 6例原发性眼眶黑色素瘤中3例死于黑色素瘤转移,1例死于无关原因,2例末次随访存活。
- 染色体获得最常见于6p、8q、17q、6q和20p;缺失最常见于1p、9p、16q和17p。
- 突变见于GNAQ(1例)、GNA11(1例)、SF3B1(2例)、NRAS(2例)和pTERT(2例)。
核心结论
- 数据提示原发性眼眶黑色素瘤存在两个基因群:类结膜黑色素瘤群和类葡萄膜黑色素瘤群,需更大样本研究证实。
研究设计与样本
- 回顾性非干预研究,纳入6例无眼睑皮肤、结膜、葡萄膜或眼外远处黑色素瘤证据的原发性眼眶黑色素瘤患者。
- 4例患者行眶内容物剜除术,2例患者行切开活检术。
- 采用HE染色和免疫组化检测S100、MelA、HMB45、Sox10和BAP1,应用阵列比较基因组杂交评估染色体拷贝数变化,并对GNAQ、GNA11、BRAF、NRAS、pTERT、SF3B1和EIF1AX进行点突变评估和Sanger测序。
主要发现
- 6例中1例临床与眼皮肤黑素细胞增多症相关,3例组织学上与良性前驱病变相关。
- 所有黑色素瘤均表达S100、MelA、HMB45和Sox10;1例患者显示BAP1核染色缺失。
- 6例中染色体获得按频率依次为6p、8q、17q、6q和20p;缺失区域最常见为1p、9p、16q和17p。
- 1例患者显示单体3和8q获得(同时显示BAP1缺失)。
- 3例患者死于黑色素瘤转移,1例死于无关原因,2例末次随访仍存活。
关键数值与推荐
- 纳入标准为原发性眼眶黑色素瘤且无眼睑皮肤、结膜、葡萄膜或眼外远处黑色素瘤证据。
- 主要结局指标包括染色体拷贝数变化、GNAQ、GNA11、BRAF、NRAS、pTERT、SF3B1和EIF1AX突变、转移存在与否及诊断至死于黑色素瘤的时间间隔、肿瘤基因图谱与临床行为的相关性。
临床怎么用
- 对原发性眼眶黑色素瘤可行基因图谱分析,以辅助区分类结膜黑色素瘤群与类葡萄膜黑色素瘤群。
- 免疫组化检测BAP1核染色缺失可能有助于识别特定基因改变的患者。
局限性
- 样本量仅6例,结论需更大规模研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze the genetic profile of 6 cases of primary orbital melanoma with clinicopathologic correlation. DESIGN: Retrospective noninterventional study to analyze the genetic profile of 6 cases of primary orbital melanoma and to correlate the genetic findings with prognosis and clinicopathologic features. Inclusion criteria were patients with primary orbital melanoma with no evidence of primary eyelid skin, conjunctival, uveal, or remote melanoma at extraocular sites. PARTICIPANTS: The study involved 6 primary orbital melanomas from 6 patients. Four patients were exenterated and 2 had incisional biopsies performed. METHODS: Clinical notes and radiologic records were assessed to ascertain clinical tumor behavior. Sections were stained with hematoxylin-eosin and exposed to immunohistochemistry for S100, MelA, HMB45, Sox10, and BAP1. Melanoma DNA was exposed to array comparative genomic hybridization to assess gross chromosomal copy number changes. Point mutation assessment and Sanger sequencing were performed for GNAQ, GNA11, BRAF, NRAS, pTERT, SF3B1, and EIF1AX. MAIN OUTCOME MEASURES: These were the presence of gross chromosomal copy number changes and the presence of mutations in GNAQ, GNA11, BRAF, NRAS, pTERT, SF3B1, and EIF1AX; the presence of metastases and time period between diagnosis and death from melanoma; and correlation between the tumor genetic profile and the clinical behavior of the tumor. RESULTS: One of the 6 cases was clinically associated with oculodermal melanocytosis. Of the 6 patients, 3 died of melanoma metastases and 1 of unrelated causes; 2 remain alive at last review. Three of the 6 cases were histologically associated with a benign precursor lesion. All melanomas expressed S100, MelA, HMB45, and Sox10. One patient showed loss of BAP1 nuclear staining. The most frequent chromosomal gains across the 6 cases, in order of frequency, were 6p, 8q, 17q, 6q, and 20p. The most frequently lost regions were 1p, 9p, 16q, and 17p. One patient showed monsomy 3 and gain of 8q (and showed the BAP1 loss). Mutations were found in GNAQ (1 case), GNA11 (1 case), SF3B1 (2 cases), NRAS (2 cases), and pTERT (2 cases). CONCLUSIONS: The data point to 2 genetic groups for primary orbital conjunctiva melanoma-like and a uveal melanoma-like group. A larger study would help confirm this suggestion.
引用
- Mudhar HS, Doherty RE, Salvi SM, et al. Genetic Profiling of Primary Orbital Melanoma: An Analysis of 6 Cases with Clinicopathologic Correlation. Ophthalmology. 2018. PMID: 30605742. doi:10.1016/j.ophtha.2018.12.047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。